Evidence map›Paper›PMID 30853725›Full record

ArticleTetrahedron2018

Total Chemical Synthesis of Human Thyroid-Stimulating Hormone (hTSH)

John A Brailsford, Jennifer L Stockdill, Abram J Axelrod, Michael T Peterson, Paul A Vadola, Eric V Johnston, Samuel J Danishefsky

Abstract read
In one paragraph

Article in Tetrahedron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Oligosaccharide Synthesis and Translational Innovation.Journal of the American Chemical Society · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

John A BrailsfordLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Jennifer L StockdillLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Abram J AxelrodLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Michael T PetersonLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Paul A VadolaLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Eric V JohnstonLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Samuel J DanishefskyLaboratory for Bioorganic Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
CANCER PHARMACOLOGYT32CA062948 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LORRAINE J GUDAS · 1994 to 2026
$12.1M
New Synthetic Reactions to Reach Bioactive ProteinsR01GM109760 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI LUO, MINKUI · 2014 to 2017
$1.7M
C-N Bond-Forming Methodologies for the Synthesis of Small Molecules and PeptidesK99GM097095 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI STOCKDILL, JENNIFER LYNN · 2011 to 2012
$120k
Synthesis of a homogenous erythropoietin via iterative native chemical and alaninF32GM100567 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI VADOLA, PAUL ANTHONY · 2012 to 2013
$76k
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA062948NIGMS NIH HHS F32 GM100567NIGMS NIH HHS K99 GM097095NIGMS NIH HHS R01 GM109760
6 · The paper itself

Abstract

The β-subunit of human thyroid stimulating hormone (hTSH) has been synthesized as a single glycoform bearing a chitobiose disaccharide at the native glycosylation site. Key to the successful completion of this synthesis was the introduction of an arginine-tagged acetamidomethyl group, which served to greatly facilitate handling of a glycopeptide fragment with poor aqueous solubility. This general solution to the challenge of working with intractable peptides is expected to find wide use in protein synthesis.

Identifiers

PMID30853725
PMCPMC6402344
OpenAlexW2790744127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.